Prothena Corporation plc
NASDAQ:PRTABiotechnology
Healthcare
$8.35 +3.89%
+$0.33 today
- Market cap
- $428.77M
- Beta
- -0.32
- P/E (TTM)
- -3.1
- EPS (TTM)
- -$2.81
52W Low $5.64High $11.80
Volume 0.76M
Average 0.51M
Balance Sheet
Inspect the capital base behind the business.
Assets
$326.80M
FY 2025 · Annual
-40.3% YoYLiabilities
$46.33M
FY 2025 · Annual
-23.0% YoYEquity
$280.47M
FY 2025 · Annual
-42.4% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 579.09M | 710.41M | 618.83M | 471.39M | 307.53M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 13K | 62K | 5.16M | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 766K | 1.71M | 3.49M | 1.17M | 1.75M |
| Total Current Assets | 584.81M | 719.1M | 639.28M | 485.41M | 315.19M |
| Property, Plant & Equipment (Net) | 14.14M | 8.01M | 16M | 13.79M | 10.27M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 860K | 860K |
| Tax Assets | 7.07M | 18.2M | 33.89M | 43.24M | 0 |
| Other Non-current Assets | 3.35M | 12.73M | 7.21M | 3.81M | 482K |
| Total Non-current Assets | 24.56M | 38.94M | 57.1M | 61.7M | 11.61M |
| Total Assets | 609.37M | 758.04M | 696.38M | 547.11M | 326.8M |
| Account Payables | 3.69M | 9.27M | 25.39M | 7.77M | 5.88M |
| Short-term Debt | 0 | 0 | 0 | 0 | 2.89M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 7.66M | 11.44M | 0 | 8.85M | 2.66M |
| Other Current Liabilities | 405K | 503K | 2.13M | 1.38M | 29.42M |
| Total Current Liabilities | 33.45M | 50.15M | 56.89M | 48.5M | 40.84M |
| Long-term Debt | 0 | 0 | 0 | 0 | 5.49M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 102.93M | 85.29M | 67.41M | 3.45M | 0 |
| Other Non-current Liabilities | 553K | 553K | 0 | 0 | (5.49M) |
| Total Non-current Liabilities | 109.87M | 85.85M | 78.13M | 11.68M | 5.49M |
| Total Liabilities | 143.32M | 135.99M | 135.02M | 60.18M | 46.33M |
| Common Stock | 466K | 521K | 537K | 538K | 538K |
| Retained Earnings | (716.05M) | (833M) | (980.03M) | (1.1B) | (1.35B) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 466.04M | 622.04M | 561.37M | 486.93M | 280.47M |
| Total Debt | 12.33M | 6.47M | 11.84M | 10.84M | 13.86M |
| Net Debt | (566.77M) | (703.93M) | (607M) | (460.55M) | (293.67M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $329.5M |
| Other Current | $9.7M |
| Total Current Assets | $339.2M |
| PP&E (Net) | $9.4M |
| Long-term Investments | $860.0K |
| Other Non-current | $482.0K |
| Total Non-current Assets | $10.7M |
| Total Assets | $349.9M |
Analysis
Selected assets total $349.9M for Latest. The largest visible component is Cash & Equivalents at $329.5M, about 94.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 3 | Initial statement of beneficial ownership | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 |
How much cash does PRTA have?
Prothena Corporation plc (PRTA) reported $307.53M in cash and equivalents in fiscal 2025.
How much debt does PRTA carry?
Prothena Corporation plc (PRTA) reported $13.86M of total debt, with net debt of -$293.67M.
Continue the stock analysis
Jump to another research area for this company.